孟德尔随机化研究显示循环尿酸水平与帕金森病无因果关系
该研究采用两样本孟德尔随机化设计,利用31个独立基因位点作为血浆尿酸的遗传工具,在包含13,708例帕金森病患者和95,282例对照的全基因组关联研究数据中评估尿酸与帕金森病的因果关系。逆方差加权法得出的效应估计为每升高1个标准差血浆尿酸水平,比值比为1.03(95%置信区间0.88-1.20),MR-Egger和惩罚加权中位数法结果相似。研究未发现尿酸对帕金森病风险存在线性因果保护作用的证据。
要点
- 孟德尔随机化分析未发现血浆尿酸水平与帕金森病风险存在因果关系。
- 逆方差加权法估计每升高1个标准差尿酸,帕金森病比值比为1.03(95%置信区间0.88-1.20)。
- 既往观察性研究中的关联可能部分归因于混杂或反向因果关系。
核心结论
- 未发现尿酸对帕金森病风险存在线性因果保护作用的证据。
- 既往观察性研究观察到的关联可能部分归因于混杂或反向因果关系。
- 在当前研究结果背景下,提高循环尿酸水平的策略可能不会降低总体帕金森病风险。
研究设计与样本
- 采用两样本孟德尔随机化设计,利用31个独立基因位点作为血浆尿酸的遗传工具。
- 基于病例对照全基因组关联研究数据,包含13,708例帕金森病患者和95,282例对照。
主要发现
- 逆方差加权法得出的效应估计为每升高1个标准差血浆尿酸水平,比值比1.03(95%置信区间0.88-1.20)。
- MR-Egger分析得出的比值比为0.99(95%置信区间0.83-1.17)。
- 惩罚加权中位数法分析得出的比值比为0.99(95%置信区间0.86-1.14)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Observational studies have shown that increased plasma urate is associated with lower risk of Parkinson's disease (PD), but these studies were not designed to test causality. If a causal relationship exists, then modulating plasma urate levels could be a potential preventive avenue for PD. We used a large two-sample Mendelian randomization (MR) design to assess for a causal relationship between plasma urate and PD risk. METHODS: We used a genetic instrument consisting of 31 independent loci for plasma urate on a case-control genome-wide association study data set, which included 13,708 PD cases and 95,282 controls. Individual effect estimates for each SNP were combined using the inverse-variance weighted (IVW) method. Two additional methods, MR-Egger and a penalized weighted median (PWM)-based approach, were used to assess potential bias attributed to pleiotropy or invalid instruments. RESULTS: We found no evidence for a causal relationship between urate and PD, with an effect estimate from the IVW method of odds ratio (OR) 1.03 (95% confidence interval [CI], 0.88-1.20) per 1-standard-deviation increase in plasma urate levels. MR Egger and PWM analyses yielded similar estimates (OR, 0.99 [95% CI, 0.83-1.17] and 0.99 [95% CI, 0.86-1.14], respectively). INTERPRETATION: We did not find evidence for a linear causal protective effect by urate on PD risk. The associations observed in previous observational studies may be, in part, attributed to confounding or reverse causality. In the context of the present findings, strategies to elevate circulating urate levels may not reduce overall PD risk. Ann Neurol 2018;84:191-199.
引用
- Kia DA, Noyce AJ, White J, et al. Mendelian randomization study shows no causal relationship between circulating urate levels and Parkinson's disease. Ann Neurol. 2018. PMID: 30014513. doi:10.1002/ana.25294
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。